Financial Performance - The company's operating revenue for the first half of 2021 was ¥444,955,510.62, representing a 26.54% increase compared to ¥351,631,050.61 in the same period last year[19]. - The net profit attributable to shareholders was ¥19,656,905.21, up 28.89% from ¥15,251,415.99 in the previous year[19]. - The net cash flow from operating activities increased by 66.03%, reaching ¥32,264,136.27 compared to ¥19,432,956.96 in the same period last year[19]. - Basic earnings per share rose to ¥0.16, a 23.08% increase from ¥0.13 in the previous year[19]. - Total assets at the end of the reporting period were ¥1,585,431,804.01, reflecting a 16.42% increase from ¥1,361,829,353.55 at the end of the previous year[19]. - The net assets attributable to shareholders increased by 1.38%, amounting to ¥1,099,333,357.92 compared to ¥1,084,356,452.71 at the end of the previous year[19]. - The company achieved operating revenue of 444.96 million yuan, an increase of 26.54% compared to the same period last year[36]. - The net profit attributable to shareholders was 19.66 million yuan, reflecting a growth of 28.89% year-on-year[36]. - The total operating revenue for the first half of 2021 reached ¥444,955,510.62, a 26.5% increase from ¥351,631,050.61 in the same period of 2020[175]. - The company reported a total profit for the first half of 2021 of ¥23,620,858.20, compared to ¥18,815,991.94 in the first half of 2020, marking a 25.0% increase[176]. Market Expansion and Product Development - The company is focused on expanding its market presence and enhancing product development strategies[26]. - The company focuses on developing, manufacturing, and selling a wide range of fitness equipment, establishing a retail network combining distribution and direct sales across China, and successfully entering international markets such as Europe, Asia-Pacific, and Canada with its IMPULSE brand[27]. - The company launched a new home fitness brand "WeSwag," targeting entry-level fitness enthusiasts, with a product line including treadmills and fitness bikes[39]. - The company is expanding its outdoor product market by optimizing its health management platform and developing smart fitness parks[40]. - The company is actively developing the overseas home product market and is constructing a new industrial park to increase production capacity for home products[44]. - The company is focusing on high-end competitive training equipment for professional sports teams and military units[38]. - The company has completed the design and development of new outdoor fitness equipment and smart testing devices[41]. - The company plans to continue expanding its market presence and investing in new product development[192]. - The company is committed to enhancing its product offerings and technological advancements in the health sector[141]. Research and Development - The company invested a total of CNY 27.22 million in research and development during the reporting period to enhance its product innovation capabilities[49]. - The company completed the development of the HSP-PRO001 and HSP-PRO002 multifunctional training machines, with performance metrics exceeding those of internationally renowned brands[50]. - The R&D team consists of 55 members, with 19 having over 10 years of experience in the fitness equipment industry, ensuring a deep understanding of market trends[61]. - The company is investing 100 million RMB in research and development for new technologies aimed at enhancing user experience[137]. - The company has developed over 900 new products and components during the reporting period, ensuring quality through rigorous testing and timely identification of issues[53]. Supply Chain and Production - The company has established a robust supply chain management system, ensuring long-term partnerships with suppliers and optimizing procurement processes[31]. - The company has adopted an OEM/ODM production model for international clients and a stock-based production model for its own brand, allowing for flexibility in meeting customer demands[31]. - The company has established a comprehensive product supply system, focusing on "multi-category, small batch, and high frequency" production, enhancing its response speed[59]. - The company is focusing on enhancing supplier management and optimizing procurement processes to reduce costs and improve supply chain efficiency[47]. Financial Health and Risks - The company faces risks related to exchange rate fluctuations, which could adversely affect profits due to international sales operations[91]. - The company is actively monitoring raw material prices, particularly steel and packaging materials, which have seen significant price increases, impacting production costs[92]. - The company has implemented measures to mitigate risks from international trade policies affecting foreign sales, including insurance coverage for clients[93]. - The company reported a significant increase in other sales revenue by 81.34%, attributed to increased venue-related income[72]. - The company has implemented cost control measures that resulted in a decrease in major expense ratios compared to the same period last year[46]. Corporate Governance and Social Responsibility - The company emphasizes corporate social responsibility, focusing on sports development and environmental protection[106]. - The company has established a comprehensive internal control system to protect the rights of shareholders, especially minority shareholders, ensuring accurate and timely information disclosure[107]. - The company has received multiple honors during the reporting period, including "National Quality Inspection Stable Qualified Products" and "2021 Shandong Province High-end Brand Cultivation Enterprise"[108]. - The company actively participates in social welfare activities, sponsoring various sports events to support national and local sports development[109]. - The company strictly adheres to environmental regulations, with all pollution control facilities operating normally and meeting discharge standards[104]. Shareholder and Equity Management - The total number of shares is 120,000,000, with 119,998,500 shares being unrestricted, representing 100% of the total shares[146]. - The largest shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., holds 33.89% of the shares, totaling 40,662,000 shares[152]. - The company reported a significant change in shareholder structure, with specific shareholders reducing their holdings[145]. - The company has disclosed various announcements related to shareholder equity changes and management of idle funds[135]. - The company has not engaged in any major asset or equity sales during the reporting period[87][88]. Future Outlook - User data showed an increase in active users, reaching 2 million, which is a 15% increase compared to the previous year[138]. - The company provided a positive outlook for the second half of 2021, projecting a revenue growth of 20% to 30%[137]. - New product launches are expected to contribute an additional 200 million RMB in revenue by the end of 2021[138]. - A new partnership with international sports organizations is anticipated to boost brand visibility and user engagement[138].

[Important Notice](index=2&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) [Board Statement and Director Attendance](index=2&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The company's board of directors, supervisory board, and senior management ensure the truthfulness, accuracy, and completeness of this quarterly report, assuming corresponding legal responsibilities, with all directors except one independent director attending the board meeting - Company management guarantees the report's truthfulness, accuracy, and completeness[4](index=4&type=chunk)[5](index=5&type=chunk) - Independent Director Li Chun was unable to attend the board meeting due to work reasons and entrusted Xu Guojun to attend on their behalf[6](index=6&type=chunk) [Company Overview](index=3&type=section&id=%E7%AC%AC%E4%BA%8C%E8%8A%82%20%E5%85%AC%E5%8F%B8%E5%9F%BA%E6%9C%AC%E6%83%85%E5%86%B5) [Major Accounting Data and Financial Indicators](index=3&type=section&id=%E4%B8%80%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) In Q1 2021, the company achieved significant performance growth with **revenue up 59.47%** and **net profit up 162.72%**, while operating cash flow improved despite remaining negative 2021 Q1 Major Financial Indicators | Indicator | Current Period (CNY) | Prior Year Period (CNY) | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 224,570,523.11 | 140,822,772.45 | 59.47% | | Net Profit Attributable to Shareholders of Listed Company | 7,150,144.52 | 2,721,587.20 | 162.72% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-recurring Gains and Losses) | 5,868,502.70 | 1,195,423.24 | 390.91% | | Net Cash Flow from Operating Activities | -29,437,920.66 | -31,588,427.93 | 6.81% | | Basic Earnings Per Share (CNY/share) | 0.06 | 0.02 | 200.00% | | Total Assets (CNY) | 1,383,176,025.28 | 1,361,829,353.55 | 1.57% (Compared to Year-end of Prior Year) | | Net Assets Attributable to Shareholders of Listed Company (CNY) | 1,091,506,597.23 | 1,084,356,452.71 | 0.66% (Compared to Year-end of Prior Year) | 2021 Q1 Non-recurring Gains and Losses Items | Item | Amount (CNY) | | :--- | :--- | | Government Grants | 1,115,348.54 | | Fair Value Changes and Investment Income from Trading Financial Assets | 414,804.68 | | Other Non-operating Income/Expenses and Asset Disposal Gains/Losses | -22,637.38 | | **Total** | **1,281,641.82** | [Shareholder Information](index=4&type=section&id=%E4%BA%8C%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E6%9C%AB%E8%82%A1%E4%B8%9C%E6%80%BB%E6%95%B0%E5%8F%8A%E5%89%8D%E5%8D%81%E5%90%8D%E8%82%A1%E4%B8%9C%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5%E8%A1%A8) As of the reporting period end, the company had 12,626 common shareholders, with top shareholders holding a significant stake, including pledged shares and concerted party relationships - As of the end of the reporting period, the company had **12,626 common shareholders**[12](index=12&type=chunk) Top Three Shareholders' Shareholding | Shareholder Name | Shareholding Percentage | Number of Shares Held | Share Status | | :--- | :--- | :--- | :--- | | Hainan Jiangheng Industrial Investment Co., Ltd. | 33.89% | 40,662,000 | Pledged 13,600,000 | | Infu China Investment Co., Ltd. | 6.11% | 7,335,200 | - | | Nantong Deyu Investment Center (Limited Partnership) | 3.96% | 4,755,200 | - | - Shareholders Hunan Cultural Tourism Venture Capital Fund (Limited Partnership) and Infu China Investment Co., Ltd. are **concerted parties**[13](index=13&type=chunk) - Shareholders Hainan Jiangheng Industrial Investment Co., Ltd., Zhao Guifen, and Chen Wuyang hold company shares through **margin trading and securities lending**[13](index=13&type=chunk) [Significant Events](index=6&type=section&id=%E7%AC%AC%E4%B8%89%E8%8A%82%20%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) [Analysis of Major Financial Data Changes](index=6&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%95%B0%E6%8D%AE%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87%E5%8F%91%E7%94%9F%E5%8F%98%E5%8A%A8%E7%9A%84%E6%83%85%E5%86%B5%E5%8F%8A%E5%8E%9F%E5%9B%A0) During the reporting period, the company experienced significant financial data changes, including **revenue growth driven by domestic and international sales**, increased selling expenses, and the impact of new lease accounting standards on the balance sheet Major Financial Data Changes and Reasons | Item | Change (%) | Primary Reason | | :--- | :--- | :--- | | **Income Statement Items** | | | | Operating Revenue | 59.47% | Growth in domestic and international sales revenue | | Operating Cost | 62.73% | Increased in line with operating revenue growth | | Selling Expenses | 63.86% | Increase in advertising and installation service fees | | Other Income | 702.98% | Increase in government grants received | | **Balance Sheet Items** | | | | Other Current Assets | 118.80% | Increase in input VAT credit | | Right-of-Use Assets | - | Implementation of new lease accounting standards | | Lease Liabilities | - | Implementation of new lease accounting standards | | Employee Compensation Payable | -82.09% | Payment of employee compensation payable at prior year-end | [Progress of Significant Matters](index=7&type=section&id=%E4%BA%8C%E3%80%81%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9%E8%BF%9B%E5%B1%95%E6%83%85%E5%86%B5%E5%8F%8A%E5%85%B6%E5%BD%B1%E5%93%8D%E5%92%8C%E8%A7%A3%E5%86%B3%E6%96%B9%E6%A1%88%E7%9A%84%E5%88%86%E6%9E%90%E8%AF%B4%E6%98%8E) The company advanced a significant external investment by participating in the establishment of an equity investment fund, which has completed its industrial and commercial registration - The company's participation in an equity investment fund has completed industrial and commercial registration, with a fund size of **CNY 31 million** and the company's subscribed capital of **CNY 10 million**[19](index=19&type=chunk) [Use of Raised Funds](index=8&type=section&id=%E4%BA%94%E3%80%81%E5%8B%9F%E9%9B%86%E8%B5%84%E9%87%91%E6%8A%95%E8%B5%84%E9%A1%B9%E7%9B%AE%E8%BF%9B%E5%B1%95%E6%83%85%E5%86%B5) The company's IPO raised **CNY 433 million**, with **CNY 194 million** cumulatively used by period-end, and **CNY 239 million** remaining, including **CNY 180 million** in large-denomination certificates of deposit - IPO net proceeds totaled **CNY 433 million**, with **CNY 194 million** cumulatively used by the end of the reporting period, leaving a balance of **CNY 239 million**[23](index=23&type=chunk) [Wealth Management](index=8&type=section&id=%E5%85%AB%E3%80%81%E5%A7%94%E6%89%98%E7%90%86%E8%B4%A2) During the reporting period, the company invested **CNY 75 million** of its own funds in bank wealth management products, with **CNY 50 million** outstanding and no overdue unrecovered amounts Wealth Management Overview (Unit: CNY 10,000) | Specific Type | Source of Funds | Amount Incurred | Outstanding Balance | Overdue Unrecovered Amount | | :--- | :--- | :--- | :--- | :--- | | Bank Wealth Management Products | Own Funds | 7,500 | 5,000 | 0 | [Financial Statements](index=10&type=section&id=%E7%AC%AC%E5%9B%9B%E8%8A%82%20%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) [Financial Statement Details](index=10&type=section&id=%E4%B8%80%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section presents the company's unaudited consolidated and parent company financial statements for Q1 2021, including the balance sheet, income statement, and cash flow statement, reflecting the financial position, operating results, and cash flows [Consolidated Balance Sheet](index=10&type=section&id=1%E3%80%81%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of March 31, 2021, total assets were **CNY 1.38 billion**, total liabilities **CNY 292 million**, and net assets attributable to shareholders **CNY 1.09 billion**, with new right-of-use assets and lease liabilities due to new lease standards Consolidated Balance Sheet Major Items (Unit: CNY) | Item | March 31, 2021 | December 31, 2020 | | :--- | :--- | :--- | | Total Assets | 1,383,176,025.28 | 1,361,829,353.55 | | Total Liabilities | 291,669,428.05 | 277,472,900.84 | | Equity Attributable to Parent Company Owners | 1,091,506,597.23 | 1,084,356,452.71 | [Consolidated Income Statement](index=15&type=section&id=3%E3%80%81%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8) In Q1 2021, total operating revenue reached **CNY 225 million**, up **59.47%**, with operating profit at **CNY 9.34 million** and net profit attributable to parent company shareholders at **CNY 7.15 million**, resulting in **basic EPS of CNY 0.06** Consolidated Income Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Total Operating Revenue | 224,570,523.11 | 140,822,772.45 | | Operating Profit | 9,343,041.37 | 3,795,629.62 | | Total Profit | 9,320,403.99 | 3,787,779.07 | | Net Profit Attributable to Parent Company Shareholders | 7,150,144.52 | 2,721,587.20 | | Basic Earnings Per Share | 0.06 | 0.02 | [Consolidated Cash Flow Statement](index=20&type=section&id=5%E3%80%81%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) Net cash flow from operating activities was **-CNY 29.44 million**, an improvement from the prior year, while net cash flow from investing activities significantly decreased to **CNY 4.40 million** due to increased investment payments Consolidated Cash Flow Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -29,437,920.66 | -31,588,427.93 | | Net Cash Flow from Investing Activities | 4,397,245.38 | 232,695,509.12 | | Net Cash Flow from Financing Activities | -158,020.21 | -7,019,454.17 | | Net Increase in Cash and Cash Equivalents | -24,691,137.61 | 195,629,601.58 | [Notes on Financial Statement Adjustments](index=23&type=section&id=%E4%BA%8C%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8%E8%B0%83%E6%95%B4%E6%83%85%E5%86%B5%E8%AF%B4%E6%98%8E) The company adopted new lease accounting standards from January 1, 2021, retrospectively adjusting initial financial statements, primarily impacting prepaid expenses, right-of-use assets, and lease liabilities without affecting owner's equity - The company adopted new lease accounting standards from **January 1, 2021**, and retrospectively adjusted the opening financial statements accordingly[55](index=55&type=chunk)[59](index=59&type=chunk) Major Impact of New Lease Standards on Opening Consolidated Balance Sheet (Unit: CNY) | Item | Adjustment Amount | | :--- | :--- | | Prepaid Expenses | -2,606,857.14 | | Right-of-Use Assets | +14,357,588.53 | | Lease Liabilities | +11,750,731.39 | [Audit Report](index=27&type=section&id=%E4%B8%89%E3%80%81%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A) The company's 2021 first-quarter report is unaudited - This quarterly report is **unaudited**[63](index=63&type=chunk)

青岛英派斯健康科技股份有限公司 2020 年年度报告全文 青岛英派斯健康科技股份有限公司 2020 年年度报告 2021-021 2021 年 04 月 1 青岛英派斯健康科技股份有限公司 2020 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人丁利荣、主管会计工作负责人朱英华及会计机构负责人(会计主 管人员)朱英华声明：保证本年度报告中财务报告的真实、准确、完整。 | 未亲自出席董事姓 | 未亲自出席董事职 | 未亲自出席会议原 | 被委托人姓名 | | --- | --- | --- | --- | | 名 | 务 | 因 | | | 陈晓东 | 董事 | 工作原因 | 丁利荣 | | 韦钢 | 董事 | 工作原因 | 丁利荣 | 除下列董事外，其他董事亲自出席了审议本次年报的董事会会议 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异。 ...

青岛英派斯健康科技股份有限公司 2020 年第三季度报告全文 青岛英派斯健康科技股份有限公司 2020 年第三季度报告 2020-069 2020 年 10 月 1 青岛英派斯健康科技股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 √ 适用 □ 不适用 单位：元 公司负责人丁利荣、主管会计工作负责人朱英华及会计机构负责人(会计主 管人员)朱英华声明：保证季度报告中财务报表的真实、准确、完整。 2 青岛英派斯健康科技股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 1,329,930,404.64 | | 1,260,719,283.95 | 5 ...

证券代码：002899 证券简称：英派斯 公告编号：2020-062 青岛英派斯健康科技股份有限公司 关于参加青岛辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流工作，构建和谐投资者关系，青岛英派斯 健康科技股份有限公司（以下简称"公司"）将参加由青岛证监局、青岛市上市 公司协会、上证所信息网络有限公司共同举办的"2020 年青岛辖区上市公司投 资者网上集体接待日"活动，现将有关事项公告如下： 本次集体接待日活动将在上证所信息网络有限公司提供的平台举行，投资者 可以登录"上证路演中心"网站（http://roadshow.sseinfo.com）或关注微信公众 号：上证路演中心，参与公司本次投资者集体接待日活动，活动时间为 2020 年 9 月 25 日（星期五）下午 15:00 至 17:00。届时公司副总经理、董事会秘书张瑞 女士、公司财务负责人朱英华女士将通过网络在线交流形式与投资者就公司治理、 发展战略、经营状况和可持续发展等投资者关注的问题进行沟通。 欢迎广大投资者积极参与。 ...

Financial Performance - The company's operating revenue for the first half of 2020 was ¥351,631,050.61, a decrease of 9.49% compared to the same period last year[18]. - The net profit attributable to shareholders was ¥15,251,415.99, representing an increase of 4.46% year-on-year[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥12,950,549.70, up 26.55% from the previous year[18]. - The net cash flow from operating activities was ¥19,432,956.96, a significant improvement of 143.77% compared to a negative cash flow in the same period last year[18]. - The total assets at the end of the reporting period were ¥1,278,828,170.07, an increase of 1.44% from the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were ¥1,060,045,946.63, up 1.46% from the end of the previous year[18]. - Basic earnings per share for the reporting period were ¥0.13, an increase of 8.33% compared to the same period last year[18]. - The company reported a net loss of approximately 3.36 million yuan for the reporting period[88]. - The company reported a total of ¥43,320.54 million in raised funds, with ¥1,689.94 million invested during the reporting period and a cumulative investment of ¥17,514.98 million[72]. Cash Flow and Investments - The net cash flow from investment activities surged by 2,489.94% to ¥318,270,159.91, mainly due to the recovery of maturing bank financial products[55]. - Cash and cash equivalents at the end of the reporting period amounted to ¥571,516,197.48, representing 44.69% of total assets, an increase from 14.34% in the same period last year due to the recovery of maturing bank wealth management products[63]. - The company has increased cash and cash equivalents by 138.14% compared to the beginning of the period, primarily due to the recovery of maturing bank wealth management products[32]. - The company has committed to several investment projects, including a fitness equipment production base upgrade with a total investment of ¥20,497.90 million, of which 24.62% has been completed[74]. - The company has engaged in entrusted wealth management with a total amount of 31,500,000 CNY, consisting of 20,500,000 CNY from raised funds and 11,000,000 CNY from self-owned funds[119]. Market and Product Development - The company has successfully penetrated international markets including Europe, Asia-Pacific, and Canada with its IMPULSE brand[31]. - The company has established a diverse product line with multiple series, including high-end, entry-level, and outdoor fitness equipment, catering to various customer needs[30]. - The company launched new products such as the AC4000 and HSP series in the overseas market, successfully entering the North American market amid rising home fitness demand[41]. - The company is adapting its product strategy to meet the growing demand for home fitness equipment due to the pandemic[42]. - The company has launched a new AI smart pathway product that integrates IoT, AI, and big data, enhancing user experience without the need for terminal devices[44]. Research and Development - The company increased its R&D investment to CNY 32.50 million, a 32.66% increase compared to the same period last year[47]. - The company focuses on R&D and has established an open product design and development system to enhance its overall research capabilities[34]. - As of June 30, 2020, the company had a core R&D team of 62 members, with 20 having over 10 years of experience in fitness equipment[35]. - The company holds a total of 236 patents, including 22 invention patents, 186 utility model patents, and 28 design patents[35]. - The company has completed over 600 tests on new products and components, ensuring quality and reliability in product development[48]. Operational Efficiency - The company improved its production efficiency by implementing automated equipment and optimizing material management systems[46]. - The company has established a comprehensive retail network combining distribution and direct sales to meet diverse consumer fitness needs[30]. - The company employs a "multi-category, small batch, high frequency" production model to enhance flexibility and responsiveness in manufacturing[33]. - The company has implemented strict quality control measures across market, process, and supplier quality, ensuring timely completion of orders[46]. Strategic Adjustments and Challenges - The company acknowledges significant pressure on traditional offline sales channels due to the rapid growth of e-commerce and changing consumer habits, impacting the profitability of retail stores[76]. - The company is facing increased operational costs for retail stores, including rent and labor, which are becoming unsustainable under current market conditions[76]. - The COVID-19 pandemic has directly affected the normal operations of retail stores, prompting the company to reassess its growth strategies[76]. - The company is committed to ensuring the effective use of raised funds and the stability of investment projects amid changing market conditions[76]. - The company has acknowledged the need for strategic adjustments in response to the evolving international market landscape[76]. Shareholder and Equity Information - The total number of shares is 120,000,000, with 40,663,500 shares (33.89%) under limited sale conditions and 79,336,500 shares (66.11%) under unrestricted sale conditions[136]. - The largest shareholder, Hainan Jiangheng Investment Co., Ltd., holds 40,662,000 shares, representing 33.89% of total shares, with no change during the reporting period[138]. - The company has 14,453 common stock shareholders at the end of the reporting period[138]. - The report indicates no significant changes in shareholding structure or major shareholder movements during the reporting period[138]. - The company has not implemented any share buyback or repurchase plans during this period[134]. Legal and Compliance Issues - The company is involved in a lawsuit with a claim amounting to approximately 46.15 million yuan[101]. - The company is involved in ongoing litigation with a claim amounting to RMB 46,152,000 due to a shareholder dispute[102]. - The half-year financial report has not been audited[99]. Environmental and Social Responsibility - The company is classified as a key pollutant discharge unit by environmental protection authorities, with specific emissions data reported[122]. - The company has implemented online monitoring for COD and pH levels in wastewater, with quarterly testing for various emissions[124][126]. - The company has not initiated any poverty alleviation work during the reporting period but plans to develop specific initiatives in the future[126].

青岛英派斯健康科技股份有限公司 2019 年年度报告全文 青岛英派斯健康科技股份有限公司 2019 年年度报告 2020-008 2020 年 04 月 1 青岛英派斯健康科技股份有限公司 2019 年年度报告全文 第一节重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连 带的法律责任。 公司负责人丁利荣、主管会计工作负责人朱英华及会计机构负责人(会计主 管人员)朱英华声明：保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次年报的董事会会议 本报告中涉及的未来发展计划等前瞻性陈述，不构成公司对投资者的实质 承诺，投资者及相关人士均应当对此保持足够的风险认识，并且应当理解计划、 预测与承诺之间的差异。 本公司请投资者认真阅读本报告，公司在本报告第四节"经营情况讨论与分 析"中"可能面临的风险和应对措施"部分，描述了公司未来经营可能面临的主要 风险，敬请广大投资者注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 | 目录 | | --- | | 第一节 | 重要提 ...

Revenue and Profitability - Revenue for Q1 2020 was CNY 140,822,772.45, a decrease of 21.47% compared to CNY 179,319,545.37 in the same period last year[8] - Net profit attributable to shareholders was CNY 2,721,587.20, an increase of 16.93% from CNY 2,327,460.03 year-on-year[8] - Net profit excluding non-recurring items dropped by 46.84% to CNY 1,195,423.24 from CNY 2,248,847.16 in the previous year[8] - Total operating revenue for the current period is ¥140,822,772.45, a decrease from ¥179,319,545.37 in the previous period, representing a decline of approximately 21.4%[42] - Net profit for the current period is ¥2,721,587.20, compared to ¥2,327,460.03 in the previous period, reflecting an increase of approximately 16.9%[44] - Operating profit for the current period is ¥3,795,629.62, up from ¥3,231,251.16, showing an increase of about 17.5%[44] - The total comprehensive income for the current period is ¥2,721,587.20, compared to ¥2,327,460.03 in the previous period, reflecting an increase of approximately 16.9%[45] Cash Flow and Financial Management - Operating cash flow improved by 51.41%, with a net cash flow of -CNY 31,588,427.93 compared to -CNY 65,016,016.89 last year[8] - Cash inflow from operating activities totaled CNY 197,307,692.98, a decrease from CNY 201,881,995.29 in the previous period[51] - Net cash outflow from operating activities was CNY -31,588,427.93, improving from CNY -65,016,016.89 year-over-year[52] - Cash inflow from investment activities amounted to CNY 293,056,856.29, down from CNY 398,366,827.01 in the prior period[52] - Net cash flow from investment activities increased significantly to CNY 232,695,509.12 compared to CNY 78,016,883.47 previously[52] - Total cash outflow from financing activities was CNY 7,019,454.17, slightly lower than CNY 7,326,250.00 in the previous period[53] - The impact of exchange rate changes on cash and cash equivalents was CNY 1,541,974.56, compared to CNY -1,086,502.38 last year[53] - Cash and cash equivalents increased by CNY 195,629,601.58 during the period, compared to an increase of CNY 11,588,114.20 in the previous period[53] Assets and Liabilities - Total assets decreased by 3.62% to CNY 1,215,072,892.46 from CNY 1,260,719,283.95 at the end of the previous year[8] - Current assets totaled ¥928,315,168.31, down from ¥968,567,679.53, indicating a decrease of about 4.2%[34] - Total current liabilities decreased to ¥163,893,079.78 from ¥211,968,655.71, a reduction of approximately 22.7%[36] - Total liabilities decreased to ¥167,556,774.62 from ¥215,924,753.31, reflecting a decline of about 22.4%[36] - Owner's equity increased to ¥1,047,516,117.84 from ¥1,044,794,530.64, a slight increase of approximately 0.3%[37] - The total liabilities as of January 1, 2020, were CNY 215,924,753.31, with current liabilities comprising CNY 211,968,655.71[59] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,389[12] - The largest shareholder, Hainan Jiangheng Industrial Investment Co., Ltd., holds 33.89% of the shares, with 40,662,000 shares pledged[12] - Basic and diluted earnings per share are both ¥0.02, unchanged from the previous period[45] Investments and Financial Management - The company reported a total of 31,500,000 CNY in entrusted financial management, with 11,000,000 CNY from self-owned funds and 20,500,000 CNY from raised funds[26] - The company has an outstanding balance of 8,500,000 CNY in entrusted financial management, with no overdue amounts[26] - The company has no derivative investments during the reporting period[27] - The company has no significant or low-security, illiquid, or non-principal-protected high-risk entrusted financial management situations reported[26] Legal and Compliance - The company is involved in a significant lawsuit with a potential liability of ¥46,152,000, which may impact financial results[20] - There are no violations of external guarantees reported during the period[28] - The company has no non-operating fund occupation by controlling shareholders or related parties[29] - The company did not conduct any research, communication, or interview activities during the reporting period[30] Operational Metrics - Research and development expenses remain stable at ¥10,811,547.08, slightly up from ¥10,694,552.56, indicating a focus on innovation[43] - The company reported a significant reduction in employee compensation payable, decreasing to ¥1,523,175.23 from ¥8,719,901.36, a decline of approximately 82.6%[36] - Deferred income tax liabilities decreased to ¥2,408,694.84 from ¥2,636,097.60, a reduction of about 8.6%[36] Changes in Accounting Standards - The company implemented new revenue recognition standards starting in 2020, adjusting accounts receivable and unearned revenue accordingly[62]

Financial Performance - Net profit attributable to shareholders decreased by 3.05% to CNY 26,775,575.77 for the reporting period[8] - Operating revenue for the period was CNY 237,714,027.65, reflecting a growth of 5.90% year-on-year[8] - Basic earnings per share decreased by 4.35% to CNY 0.22[8] - The weighted average return on net assets was 2.62%, down by 0.21% from the previous year[8] - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses of CNY 20,663,752.43, a decrease of 20.89% year-on-year[8] - The total operating profit for the year-to-date period was CNY 51,855,688.90, an increase from CNY 48,964,424.58 in the previous year[53] - The total profit for the year-to-date period was CNY 51,799,975.19, down from CNY 55,201,309.80 in the same period last year[53] - The total comprehensive income for Q3 2019 was CNY 26,775,575.77, down from CNY 27,618,355.44 in the same quarter last year[49] Assets and Liabilities - Total assets increased by 2.37% to CNY 1,303,169,004.42 compared to the end of the previous year[8] - The company's current assets reached CNY 987,104,879.72, compared to CNY 948,166,336.61 at the end of 2018, reflecting a growth of approximately 4.1%[35] - Total liabilities stood at CNY 267,556,480.96, slightly up from CNY 267,516,506.78 at the end of 2018[37] - The company's equity remained stable at CNY 1,035,612,523.46, unchanged from the previous reporting period[37] - The total equity attributable to shareholders reached CNY 1,005,516,837.51, with retained earnings of CNY 227,756,652.92[71] Cash Flow - The net cash flow from operating activities was negative at CNY -11,205,117.42, a decline of 72.12% compared to the same period last year[8] - Net cash flow from operating activities decreased by 69.20% to -¥55,598,639.01, mainly due to higher cash payments for goods purchased compared to the previous year[16] - The cash flow from financing activities showed a net outflow of -11,503,453.28 RMB, compared to -9,633,236.19 RMB in the previous year, reflecting increased financial obligations[66] Research and Development - R&D expenses rose by 57.32% to ¥41,390,553.16, reflecting the company's increased investment in research and development[16] - Research and development expenses for Q3 2019 were CNY 16.89 million, an increase of 53.06% compared to CNY 11.04 million in Q3 2018[45] - The company approved an additional investment of 26 million RMB for the R&D center construction project, extending the completion deadline to September 14, 2021[21] Shareholder Information - The total number of shareholders at the end of the reporting period was 16,041[12] - The largest shareholder, Hainan Jiangheng Industrial Co., Ltd., held 33.89% of the shares, amounting to 40,662,000 shares[12] Legal and Regulatory Matters - The company is currently involved in multiple lawsuits, with ongoing proceedings that could influence future financial outcomes[19] - The company’s total liabilities related to ongoing litigation amount to ¥46,152,000, with no expected impact on financial results at this time[18] Future Outlook and Strategy - Future outlook includes a projected revenue growth of 10% for Q4 2019[78] - The company is investing in new product development, with a budget allocation of 5 million RMB for R&D in the next quarter[78] - Market expansion plans include entering two new provinces by the end of 2019[78] - A new marketing strategy is set to launch in Q4, aiming to increase brand awareness by 30%[78] - The company plans to enhance its online sales platform, targeting a 25% increase in e-commerce revenue[78]

证券代码：002899 证券简称：英派斯 公告编号：2019-060 青岛英派斯健康科技股份有限公司 关于参加青岛辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流工作，构建和谐投资者关系，青岛英派斯 健康科技股份有限公司（以下简称"公司"）将参加由青岛证监局、青岛市上市 公司协会、上证所信息网络有限公司共同举办的"2019 年青岛辖区上市公司投 资者网上集体接待日"活动，现将有关事项公告如下： 本次集体接待日活动将在上证所信息网络有限公司提供的平台举行，投资者 可以登录"上证路演中心"网站（http://roadshow.sseinfo.com）或关注微信公众 号：上证路演中心，参与公司本次投资者集体接待日活动，活动时间为 2019 年 9 月 20 日（星期五）下午 15:00 至 17:00。届时公司财务负责人朱英华女士、公 司副总经理、董事会秘书张瑞女士将通过网络在线交流形式与投资者就公司治理、 发展战略、经营状况和可持续发展等投资者关注的问题进行沟通。 欢迎广大投资者积极参与。 ...